Definition:
CPT® 86141 describes a laboratory test used to detect hepatitis B surface antibodies (anti-HBs) in the blood. This test determines immune status following vaccination or prior exposure to hepatitis B and helps guide clinical decisions for vaccination or further evaluation.
When to Use:
- To assess immunity after hepatitis B vaccination or potential exposure.
- For patients at risk of hepatitis B infection, including healthcare workers or individuals with high-risk behaviors.
- As part of a pre-vaccination or post-exposure screening protocol.
Documentation Requirements:
To support billing for CPT® 86141, clinicians should document:
- Medical necessity, including vaccination history or potential exposure.
- Relevant patient risk factors and clinical indications.
- Any follow-up plans based on antibody results, including additional vaccination or monitoring.
Key Notes:
- CPT® 86141 specifically tests for hepatitis B surface antibodies; other hepatitis B markers are billed separately.
- Accurate documentation ensures payer compliance and supports proper reimbursement.
How OptiMantra Supports 86141:
OptiMantra’s EMR and practice management platform enables providers to order hepatitis B antibody tests directly from the chart, track clinical indications, and automatically integrate results into patient records. This streamlines documentation, supports clinical decision-making, and ensures clean, compliant claims for faster reimbursement.
.png)
